Search hospitals > California > Los Angeles
Los Angeles County-USC Medical Center
Claim this profileLos Angeles, California 90033
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Cancer
Conducts research for AIDS
Conducts research for Lung Cancer
499 reported clinical trials
46 medical researchers
Summary
Los Angeles County-USC Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Cancer, AIDS, Lung Cancer and other specialties. Los Angeles County-USC Medical Center is involved with conducting 499 clinical trials across 730 conditions. There are 46 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, David Hong, MD, and Jacob Thomas, MD.Top PIs
Anthony El-Khoueiry, MDUSC Norris Comprehensive Cancer Center2 years of reported clinical research
Expert in Solid Tumors
Expert in Cancer
35 reported clinical trials
53 drugs studied
Heinz-Josef LenzUSC / Norris Comprehensive Cancer Center7 years of reported clinical research
Expert in Colorectal Cancer
Studies Colon Cancer
33 reported clinical trials
61 drugs studied
David Hong, MDM D Anderson Cancer Center4 years of reported clinical research
Expert in Pancreatic Cancer
Expert in Solid Tumors
32 reported clinical trials
61 drugs studied
Jacob Thomas, MDUSC Norris Comprehensive Cancer Center1 year of reported clinical research
Studies Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
23 reported clinical trials
33 drugs studied
Clinical Trials running at Los Angeles County-USC Medical Center
Prostate Cancer
Breast Cancer
Cancer
Bladder Cancer
Lung Cancer
Esophageal cancer
Breast cancer
Kidney Cancer
Pancreatic Cancer
Small Cell Lung Cancer
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Los Angeles County-USC Medical Center?
Los Angeles County-USC Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Cancer, AIDS, Lung Cancer and other specialties. Los Angeles County-USC Medical Center is involved with conducting 499 clinical trials across 730 conditions. There are 46 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, David Hong, MD, and Jacob Thomas, MD.
Where is Los Angeles County-USC Medical Center located?
**Los Angeles County-USC Medical Center**
- **Address:** 1200 N State St, Los Angeles, CA 90033.
- **Public Transit:** Bus lines 251 and METRO J LINE 910/950 or B and D subway lines.
- **Driving:** Utilize real-time driving directions for the best route based on current traffic updates and road conditions.
Who should I call to ask about financial aid or insurance network?
**Los Angeles County-USC Medical Center Financial Assistance Information:**
- For Medi-Cal applications and inquiries, contact the DPSS Customer Service Center at (866) 613-3777.
- The "Ability to Pay Program" (ATP) provides free services for patients with income at or below 200% Federal Poverty Level (FPL) and reduced-cost services on a sliding scale for those above 200% FPL.
- For assistance with bill payments, contact patient financial services, available Monday to Friday, 8:00 am to 4:00 pm.
What insurance does Los Angeles County-USC Medical Center accept?
The Los Angeles County-USC Medical Center accepts a range of insurance plans, such as Medicare, PPO, and Self Pay. For a detailed list of accepted insurance plans, please contact the hospital directly or visit their official website.
What awards or recognition has Los Angeles County-USC Medical Center received?
Los Angeles County-USC Medical Center (LAC+USC) is renowned for its high-quality care, especially given its limited resources. In 2022, its initiative to reduce patient falls in the acute-care medical surgical jail ward earned recognition in the Excellence and Innovation in Care 2022 Gage Awards by America's Essential Hospitals. This accolade highlights LAC+USC's commitment to enhancing patient outcomes and advancing healthcare equity.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.